Bridgeway Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-19,000
| Closed | -$374K | – | 1274 |
|
|
2021
Q3 | $374K | Hold |
19,000
| – | – | 0.01% | 1116 |
|
|
2021
Q2 | $418K | Buy |
19,000
+3,200
| +20% | +$70.4K | 0.01% | 1117 |
|
|
2021
Q1 | $376K | Hold |
15,800
| – | – | 0.01% | 1178 |
|
|
2020
Q4 | $413K | Sell |
15,800
-1,600
| -9% | -$41.8K | 0.01% | 1017 |
|
|
2020
Q3 | $303K | Buy |
+17,400
| New | +$303K | 0.01% | 1064 |
|
|
2019
Q2 | – | Sell |
-45,600
| Closed | -$535K | – | 1332 |
|
|
2019
Q1 | $535K | Sell |
45,600
-15,800
| -26% | -$185K | 0.01% | 1007 |
|
|
2018
Q4 | $820K | Buy |
61,400
+30,400
| +98% | +$406K | 0.01% | 809 |
|
|
2018
Q3 | $435K | Hold |
31,000
| – | – | ﹤0.01% | 1178 |
|
|
2018
Q2 | $487K | Hold |
31,000
| – | – | ﹤0.01% | 1139 |
|
|
2018
Q1 | $510K | Sell |
31,000
-5,300
| -15% | -$87.2K | 0.01% | 1089 |
|
|
2017
Q4 | $656K | Sell |
36,300
-1,500
| -4% | -$27.1K | 0.01% | 1004 |
|
|
2017
Q3 | $730K | Sell |
37,800
-13,900
| -27% | -$268K | 0.01% | 962 |
|
|
2017
Q2 | $610K | Hold |
51,700
| – | – | 0.01% | 1027 |
|
|
2017
Q1 | $567K | Hold |
51,700
| – | – | 0.01% | 1031 |
|
|
2016
Q4 | $375K | Buy |
+51,700
| New | +$375K | ﹤0.01% | 1175 |
|